The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer

Szász, Attila Marcell; Li, Qiyuan; Eklund, Aron C.; Sztupinszki, Zsófia; Rowan, Andrew; Tőkés, Anna-Mária; Székely, Borbála; Kiss, András; Szendrői, Miklós; Győrffy, Balázs; Szállási, Zoltán; Swanton, Charles; Kulka, Janina
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Purpose: Quantifying chromosomal instability (CIN) has both prognostic and predictive clinical utility in breast cancer. In order to establish a robust and clinically applicable gene expression-based measure of CIN, we assessed the ability of four qPCR quantified genes selected from the 70-gene Chromosomal Instability (CIN70) expression signature to stratify outcome in patients with grade 2 breast cancer. Methods: AURKA, FOXM1, TOP2A and TPX2 (CIN4), were selected from the CIN70 signature due to their high level of correlation with histological grade and mean CIN70 signature expression in silico. We assessed the ability of CIN4 to stratify outcome in an independent cohort of patients diagnosed between 1999 and 2002. 185 formalin-fixed, paraffin-embedded (FFPE) samples were included in the qPCR measurement of CIN4 expression. In parallel, ploidy status of tumors was assessed by flow cytometry. We investigated whether the categorical CIN4 score derived from the CIN4 signature was correlated with recurrence-free survival (RFS) and ploidy status in this cohort. Results: We observed a significant association of tumor proliferation, defined by Ki67 and mitotic index (MI), with both CIN4 expression and aneuploidy. The CIN4 score stratified grade 2 carcinomas into good and poor prognostic cohorts (mean RFS: 83.8±4.9 and 69.4±8.2 months, respectively, p = 0.016) and its predictive power was confirmed by multivariate analysis outperforming MI and Ki67 expression. Conclusions: The first clinically applicable qPCR derived measure of tumor aneuploidy from FFPE tissue, stratifies grade 2 tumors into good and poor prognosis groups.


Related Articles

  • Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. Andres, Sarah A.; Brock, Guy N.; Wittliff, James L. // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Genomics provides opportunities to develop precise tests for diagnostics, therapy selection and monitoring. From analyses of our studies and those of published results, 32 candidate genes were identified, whose expression appears related to clinical outcome of breast cancer....

  • Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer. Rothé, Françoise; Ignatiadis, Michail; Chaboteaux, Carole; Haibe-Kains, Benjamin; Kheddoumi, Naïma; Majjaj, Samira; Badran, Bassam; Fayyad-Kazan, Hussein; Desmedt, Christine; Harris, Adrian L.; Piccart, Martine; Sotiriou, Christos // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Purpose: Aberrant microRNA (miRNA) expression is associated with cancer and has potential diagnostic and prognostic value in various malignancies. In this study, we investigated miRNA profiling as a complementary tool to improve our understanding of breast cancer (BC) biology and to assess...

  • Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study. Francz, Monika; Egervari, Kristof; Kardos, Laszlo; Toth, Judit; Nemes, Zoltan; Szanto, Janos; Szollosi, Zoltan // Journal of Clinical Pathology;Apr2010, Vol. 63 Issue 4, p341 

    Aims The current study was done as a validation study prior to setting up a clinical HER2 testing service using the new commercial Poseidon HER2 fluorescence in situ hybridisation (FISH) assay. However, it was felt that the experience of the authors of this study may be of interest to other...

  • Klinefelter-syndrome and other X-chromosomal aneuploidies.  // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Apr2008, Vol. 16 Issue 4, p503 

    The article presents information on Klinefelter-syndrome and other X-chromosomal aneuploidies. It states that Klinefelter's syndrome which is a frequent sex chromosomal disorder in males, is associated with increased mortality, diabetes, metabolic syndrome and possibly breast cancer. It is...

  • Bayesian Mixture Models for Assessment of Gene Differential Behaviour and Prediction of pCR through the Integration of Copy Number and Gene Expression Data. Trentini, Filippo; Ji, Yuan; Iwamoto, Takayuki; Qi, Yuan; Pusztai, Lajos; Müller, Peter // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    We consider modeling jointly microarray RNA expression and DNA copy number data. We propose Bayesian mixture models that define latent Gaussian probit scores for the DNA and RNA, and integrate between the two platforms via a regression of the RNA probit scores on the DNA probit scores. Such a...

  • Prognostic value of maspin mRNA expression in ERa-positive postmenopausal breast carcinomas. Bieche, I; Girault, I; Sabourin, J-C; Tozlu, S; Driouch, K; Vidaud, M; Lidereau, R // British Journal of Cancer;3/24/2003, Vol. 88 Issue 6, p863 

    Maspin, a member of the serpin family, has a role in cell migration, angiogenesis and apoptosis. Little is known of the clinical significance of maspin gene expression in human cancers. We developed a real-time quantitative RT-PCR assay to quantify the full range of maspin mRNA copy numbers in a...

  • Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer. Relles, Daniel; Sendecki, Jocelyn; Chipitsyna, Galina; Hyslop, Terry; Yeo, Charles; Arafat, Hwyda // Journal of Gastrointestinal Surgery;Mar2013, Vol. 17 Issue 3, p443 

    Introduction: The circadian rhythm is responsible for physiologic homeostasis, behavior, and components of multiple metabolic processes. Disruption of the circadian rhythm is associated with cancer development, and several circadian clock genes have been implicated in loss of cell cycle control,...

  • CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma. Ronchi, Cristina L.; Sbiera, Silviu; Volante, Marco; Steinhauer, Sonja; Scott-Wild, Vanessa; Altieri, Barbara; Kroiss, Matthias; Bala, Margarita; Papotti, Mauro; Deutschbein, Timo; Terzolo, Massimo; Fassnacht, Martin; Allolio, Bruno // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Background: Adrenocortical tumors comprise frequent adenomas (ACA) and rare carcinomas (ACC). Human cytochrome P450 2W1 (CYP2W1) is highly expressed in some cancers holding the potential to activate certain drugs into tumor cytotoxins. Objective: To investigate the CYP2W1 expression in adrenal...

  • Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT. Roundhill, E; Burchill, S // British Journal of Cancer;7/9/2013, Vol. 109 Issue 1, p195 

    Background:Primary Ewing's sarcoma family of tumours (ESFTs) may respond to chemotherapy, although many patients experience subsequent disease recurrence and relapse. The survival of ESFT cells following chemotherapy has been attributed to the development of resistant disease, possibly through...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics